1. Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion‐associated graft‐versus‐host disease. Issue 6 (2nd April 2018) Authors: Castro, Grace; Merkel, Patricia A.; Giclas, Hannah E.; Gibula, Andrew; Andersen, Gillian E.; Corash, Laurence M.; Lin, Jin Sying; Green, Jennifer; Knight, Vijaya; Stassinopoulos, Adonis Journal: Transfusion Issue: Volume 58:Issue 6(2018) Page Start: 1506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inactivation of chikungunya virus in blood components treated with amotosalen/ultraviolet A light or amustaline/glutathione. Issue 3 (10th January 2018) Authors: Laughhunn, Andrew; Huang, Yan‐Jang S.; Vanlandingham, Dana L.; Lanteri, Marion C.; Stassinopoulos, Adonis Journal: Transfusion Issue: Volume 58:Issue 3(2018) Page Start: 748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Transfusion‐associated graft‐versus‐host disease reexamined: potential for improved prevention using a universally applied intervention. Issue 11 (28th September 2018) Authors: Kleinman, Steven; Stassinopoulos, Adonis Journal: Transfusion Issue: Volume 58:Issue 11(2018) Page Start: 2545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗